A Study of Combinations of D-CIK Immunotherapy And Anti-PD-1 In Refractory Solid Tumors
Status: UNKNOWN
Study type: INTERVENTIONAL
Conditions: Hepatocellular Carcinoma|Renal Cell Carcinoma|Bladder Cancer|Colorectal Cancer|Non-small-cell Lung Cancer|Breast Cancer
Interventions: BIOLOGICAL: D-CIK and anti-PD-1 antibody
Sponsor: Sun Yat-sen University